Debate on Hydroxychloroquineâs efficacy: Why we need to be careful about research papers
The retraction of the Lancet study and the restart of HCQ trial by WHO do not mean that the debate on HCQ#39;s efficacy is settled
from Moneycontrol Business News https://www.moneycontrol.com/news/business/debatehydroxychloroquineâs-efficacy-why-we-need-to-be-careful-about-research-papers_13871081.html
from Moneycontrol Business News https://www.moneycontrol.com/news/business/debatehydroxychloroquineâs-efficacy-why-we-need-to-be-careful-about-research-papers_13871081.html
No comments: